Timing of SV40 oncogene activation by site-specific recombination determines subsequent tumor progression during murine lens development - PubMed (original) (raw)

. 1993 Dec;8(12):3333-42.

Affiliations

PMID: 8247535

Timing of SV40 oncogene activation by site-specific recombination determines subsequent tumor progression during murine lens development

J G Pichel et al. Oncogene. 1993 Dec.

Abstract

We generated mice that carry copies of a dormant transgene encoding the SV40 tumor antigens. The transgenes are specifically targeted to the lens and contain features that render their expression dependent on the action of Cre, a site-specific bacteriophage DNA recombinase. Timing of oncogene activation was controlled by making Cre available either prior to, or coincident with, the onset of primary fiber differentiation in the embryonic lens vesicle. Early expression of Cre resulted in oncogene activation in undifferentiated lens epithelial cells that rapidly proliferated inside the lens capsule. By contrast, when Cre accumulation was delayed to coincide with the onset of primary lens fiber differentiation, SV40 oncogenes were activated in cells that had begun to elongate and to accumulate lens-specific crystallins. During subsequent proliferation inside the lens capsule, transformed progeny cells maintained the profile of fiber differentiation that their parent cells had acquired at the time of oncogenic conversion. Developing lens tumors were confined within the capsule of the embryonic lens. However, if the capsule was perforated in an embryonic eye in organ culture, cells rapidly grew out while still maintaining features of differentiation. Our findings show that the differentiated state of the primary target cells is an important parameter of subsequent lens oncogenesis, and that an intact lens capsule can restrict invasive neoplastic growth.

PubMed Disclaimer

Cited by

Cataracts in transgenic mice caused by a human papillomavirus type 18 E7 oncogene driven by KRT1-14.
Ghim S, Jenson AB, Bubier JA, Silva KA, Smith RS, Sundberg JP. Ghim S, et al. Exp Mol Pathol. 2008 Oct;85(2):77-82. doi: 10.1016/j.yexmp.2008.07.004. Epub 2008 Aug 6. Exp Mol Pathol. 2008. PMID: 18723014 Free PMC article.
Site-specific recombination mediated by an adenovirus vector expressing the Cre recombinase protein: a molecular switch for control of gene expression.
Anton M, Graham FL. Anton M, et al. J Virol. 1995 Aug;69(8):4600-6. doi: 10.1128/JVI.69.8.4600-4606.1995. J Virol. 1995. PMID: 7609024 Free PMC article.
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso M, Pichel JG, Gorman JR, Sauer B, Okamoto Y, Lee E, Alt FW, Westphal H. Lakso M, et al. Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5860-5. doi: 10.1073/pnas.93.12.5860. Proc Natl Acad Sci U S A. 1996. PMID: 8650183 Free PMC article.
Different thermostabilities of FLP and Cre recombinases: implications for applied site-specific recombination.
Buchholz F, Ringrose L, Angrand PO, Rossi F, Stewart AF. Buchholz F, et al. Nucleic Acids Res. 1996 Nov 1;24(21):4256-62. doi: 10.1093/nar/24.21.4256. Nucleic Acids Res. 1996. PMID: 8932381 Free PMC article.
Hierarchical composition of reliable recombinase logic devices.
Guiziou S, Mayonove P, Bonnet J. Guiziou S, et al. Nat Commun. 2019 Jan 28;10(1):456. doi: 10.1038/s41467-019-08391-y. Nat Commun. 2019. PMID: 30692530 Free PMC article.

Timing of SV40 oncogene activation by site-specific recombination determines subsequent tumor progression during murine lens development - PubMed (original) (raw)